课题基金 / 基金详情

Development of HLA bound peptitides which have supressive activity.

Development of HLA bound peptitides which have supressive activity.
开发具有抑制活性的 HLA 结合肽。
批准号:
04557027
负责人:
SASAZUKI Takehiko
金额:
$12.1万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

SASAZUKI Takehiko的其他基金

相似基金

相关文献

中文摘要
翻译
有许多疾病是由免疫反应异常引起的。为了开发与人类白细胞抗原分子结合的非刺激性多肽类似物,我们研究了人类白细胞抗原与多肽的相互作用。研究了人类白细胞抗原-DP9(DPA1*0201/DPB1*0901)分子与12型(SS95/12)链球菌M蛋白的相互作用。共鉴定出7个受人类白细胞抗原-DP9分子限制的抗原肽。比较这些多肽的氨基酸序列,发现了与HLA-DP9特异的结合基序,这与与HLA-DR分子的结合基序不同。在分析人类白细胞抗原-DR51和-DQ6转基因小鼠对合成肽的反应时,我们发现DR51和DQ6转基因小鼠对合成肽有显著的T细胞应答。提示人类白细胞抗原转基因小鼠可作为体内检测人类白细胞抗原分子功能的有用工具。本研究还建立了人类白细胞抗原A、DR、DQ、DP等位基因的PCR/SSOP分型方法,发现了几个新的等位基因。利用这种方法,我们确定了几个自身免疫性疾病的易感基因。
英文摘要
There are many diseases caused by abnormal immune responses. To develop the non stimulatory peptide analog that binds to HLA molecule, we investigated the HLA-peptide interactions. Interaction of HLA-DP9 (DPA1*0201/DPB1*0901) molecule and M protein of serotype 12 (SS95/12) streptococcus has been investigated. Seven antigenic peptides restricted by the HLA-DP9 molecule were identified. Comparison of the amino acid sequences among these peptides revealed HLA-DP9-specific binding motif, which differs from the binding motif to the HLA-DR molecules. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to the peptides. This indicated that HLA transgenic mouse should be a useful tool to examine the function of HLA molecules in vivo. We also developed the DNA typing method using PCR/SSOP analysis for HLA-A,HLA-DR,DQ and DP alleles, and found several new alleles. Using this method we determined several susceptible genes for autoimmune disease.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Yoshizumi H,et al: "Generation of CD8_+ cytotoxic T lymphocytes that shows soluble factor-dependent lysis of autologous antigen presenting cells." Eur. J. Immunol.23. 3173-3180 (1994)
Yoshizumi H 等人:“CD8+ 细胞毒性 T 淋巴细胞的产生,显示出自体抗原呈递细胞的可溶性因子依赖性裂解。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fukui Y: "T cell repertoire in a transgenic C57BL/6 mice expressing the HLA-DRA gene on the X chromosome" Immunogenetics. 37. 204-211 (1993)
Fukui Y:“在 X 染色体上表达 HLA-DRA 基因的转基因 C57BL/6 小鼠中的 T 细胞库”免疫遗传学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wan XL,et al.: "HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's Throiditis." Hum, Immunol.(in press).
Wan XL 等人:“HLA-A 和 DRB4 基因控制桥本甲状腺炎的易感性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wan XL, et al: "HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's Thyroiditis." Hum. Immunol.(in press).
Wan XL 等人:“HLA-A 和 DRB4 基因控制桥本甲状腺炎的易感性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 22 条
    Immunogenetic Analysis of Autoimmune Thyroid Diseases
    Mechanisms of oncogenesis and anti-oncogenesis
    Development of soluble TCR and soluble MHC/peptide compelx with high affinity for their ligands
    • 批准号:
      08557026
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $7.68万
    • 财政年份:
      1996
    • 负责人:
      SASAZUKI Takehiko
    • 依托单位:
    Molecular Basis of Immunological Tolerance and Non-Response
    • 批准号:
      08044302
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $5.76万
    • 财政年份:
      1996
    • 负责人:
      SASAZUKI Takehiko
    • 依托单位:
    海外基金